Burning Rock Biotech Ltd (BNR) is down -16.74% in one week, should you hold out?

Note 21 InvestorsObserver giving shares of Burning Rock Biotech Ltd (BNR) puts it near the bottom of the diagnostics and research industry. In addition to scoring more than 11% of stocks in diagnostics and research, BNR’s overall rating of 21 means the stock scores better than 21% of all stocks.

BNR has an overall score of 21. Find out what this means for you and get the rest of the rankings on BNR!

What do these notes mean?

Finding the best stocks to invest in can be difficult. There are thousands of options and it can be confusing to know what really constitutes great value. InvestorsObserver lets you choose from eight unique metrics to display the top industries and top performing stocks within that industry. A score of 21 would be higher than 21% of all actions. Our proprietary rating system captures technical factors, fundamental analysis and the opinions of Wall Street analysts. This makes InvestorsObserverThe overall rating of is a great place to start, regardless of your investing style. Scores ranked in percentiles are also easy to understand. A score of 100 is high and a 0 is low. There’s no need to try to remember what’s “good” for a bunch of complicated ratios, just pay attention to the higher numbers.

What’s going on with Burning Rock Biotech Ltd shares today?

Burning Rock Biotech Ltd (BNR) stock gained 2.29% while the S&P 500 fell -0.37% at 2:15 p.m. Tuesday, June 14. BNR was up $0.04 from the previous closing price of $1.75 on volume of 788,318 shares. Over the past year, the S&P 500 is down -12.21% while the BNR has fallen -93.85%. BNR has lost -$1.26 per share over the past 12 months. Click here for the full Burning Rock Biotech Ltd stock report.

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.

Thank you for signing up! You are ready to receive the Morning Update newsletter